Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities

Area of Science:

• Genetics
• Nephrology
• Molecular Biology

Background:

• Hypertension is a major cardiovascular disease risk factor.
• Pseudohypoaldosteronism type II (PHAII) is a rare genetic syndrome causing hypertension, hyperkalemia, and metabolic acidosis.
• PHAII offers insights into renal salt and electrolyte homeostasis.

Purpose of the Study:

• To identify the genetic causes of PHAII.
• To elucidate the physiological mechanisms underlying PHAII.
• To explore the role of KLHL3 and CUL3 in blood pressure regulation.

Main Methods:

• Exome sequencing was used to identify mutations in PHAII patients.
• Analysis of KLHL3 and CUL3 gene mutations and their inheritance patterns.
• Investigated the function of KLHL3 and CUL3 in E3 ligase complexes.
• Examined the expression of KLHL3 and CUL3 in the kidney.

Main Results:

• Mutations in KLHL3 or CUL3 were identified in 41 PHAII families.
• KLHL3 mutations can be recessive or dominant; CUL3 mutations are dominant and often de novo.
• Both KLHL3 and CUL3 mutations disrupt ubiquitination processes.
• Disease symptoms were ameliorated by thiazide diuretics, implicating the Na-Cl cotransporter.

Conclusions:

• KLHL3 and CUL3 are critical for maintaining blood pressure, potassium, and pH homeostasis.
• Mutations in KLHL3 and CUL3 cause PHAII through mechanisms involving renal salt reabsorption.
• Exome sequencing is effective for identifying disease genes in complex genetic disorders.